IL-18 binding protein (IL-18BP) in inflammatory diseases
US11530263B2 · kind B2 · utility
2Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 2020 |
| Grant date | Dec 20, 2022 |
| Priority date | — |
| Expiry date | May 26, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the indications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.